Phase 2a, Open-Label, 4-Escalating-Dose, Randomized Multicenter Study Evaluating the Safety and Activity of Ferroquine (SSR97193) Plus Artesunate, versus Amodiaquine Plus Artesunate, in African Adult Men with Uncomplicated Plasmodium falciparum Malaria
一项 2a 期、开放标签、4 剂量递增、随机多中心研究，旨在评估 Ferroquine (SSR97193) 联合青蒿琥酯与 Amodiaquine 联合青蒿琥酯在患有无并发症恶性疟原虫疟疾的非洲成年男性中的安全性和活性。
期刊:American Journal of Tropical Medicine and Hygiene
影响因子:1.6
doi:10.4269/ajtmh.16-0731
Supan, Christian; Mombo-Ngoma, Ghyslain; Kombila, Maryvonne; Ospina Salazar, Carmen L; Held, Jana; Lell, Bertrand; Cantalloube, Cathy; Djeriou, Elhadj; Ogutu, Bernhards; Waitumbi, John; Otsula, Nekoye; Apollo, Duncan; Polhemus, Mark E; Kremsner, Peter G; Walsh, Douglas S
